NPHLA Daily
NPHLA Daily
Tuesday, November 17, 2026 · 4-minute read
Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.
Top development today
What changed today in Regulatory: 11 recall records, 1 proposed rule
NPHLA tracked 12 new official records on this desk today: 11 recall records, 1 proposed rule. First: Class II: TIRZEPATIDE/L-CARNITINE **10/50MG/ML** (MDV) **1ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas — reason given: Lack of Processing Controls (firm: Victory Medical Center Pharmacy).
Metabolic signal
What changed today in Metabolic: 5 trial updates
NPHLA tracked 5 new official records on this desk today: 5 trial updates. First: Results posted on ClinicalTrials.gov: SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
Regulatory signal
Class II recall: SEMAGLUTIDE/L-CARNITINE 2.5/25MG/ML **1ML** MDV, VMC, Victory Medical Center Pharmacy, Austin, Texas
Reason: Lack of Processing Controls. Recalling firm: Victory Medical Center Pharmacy (TX). Status: Ongoing.
Aesthetics & Longevity signal
What changed today in Aesthetics & Longevity: 2 new studies, 1 trial update
NPHLA tracked 3 new official records on this desk today: 2 new studies, 1 trial update. First: New research in International journal of pharmaceutics: “Extracellular matrix hydrogel modified by miR-21-overexpressing keratinocyte-derived exosomes accelerates burn wound healing”.
One thing worth watching
Comments close: Compounding Animal Drugs From Bulk Drug Substances: Compounding Under CGMP in Federally-Registered Facilities; Draft Guidance for Industry; Availability; Agency Information…
November 26, 2026 — verified from the Federal Register comments_close_on.
5 things to know
- What changed today in Regulatory: 11 recall records, 1 proposed rule
- What changed today in Metabolic: 5 trial updates
- What changed today in Aesthetics & Longevity: 2 new studies, 1 trial update
- What changed today in Metabolic: 1 new study
- Class II recall: SEMAGLUTIDE/L-CARNITINE 2.5/25MG/ML **1ML** MDV, VMC, Victory Medical Center Pharmacy, Austin, Texas (U.S. Food and Drug Administration (Enforcement Report))
Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.

